Exec Director, Global Commercial Product Strategy - Lenacapavir for Prevention

Gilead Sciences(25 days ago)

HybridFull TimeDirector$281,010 - $363,660Commercial

About this role

The Executive Director, Global Commercial Product Strategy for Lenacapavir for Prevention at Gilead leads the global commercial vision and long-range strategy for the lenacapavir HIV prevention portfolio. This role guides global launch preparation and early commercial planning for future prevention assets while partnering across regions and functions to enable market development and sustained growth.

View Original Listing

Required Skills

Global Strategy
Launch Planning
Market Development
Cross-Functional Leadership
Stakeholder Management
Brand Positioning
Evidence Strategy
People Leadership
Strategic Thinking
Analytical Skills

About Gilead Sciences

gilead.com

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.

View more jobs at Gilead Sciences →